Search research articles
Contact Us
Filters
Showing results (481-490 of 527) with videos related to
Page
of 53
Sort By:
The New England Journal of Medicine
|
June 10, 2008
Effects of intensive glucose lowering in type 2 diabetes
, Hertzel C Gerstein, Michael E Miller, et al.
The New England Journal of Medicine
|
March 4, 2011
Long-term effects of intensive glucose lowering on cardiovascular outcomes
, Hertzel C Gerstein, Michael E Miller, et al.
Human Genetics
|
March 30, 2017
Genetic associations with lipoprotein subfraction measures differ by ethnicity in the multi-ethnic study of atherosclerosis (MESA)
Zhe Wang, Ani Manichukal, David C Goff, et al.
Circulation
|
July 31, 2015
Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines
Joseph Yeboah, Tamar S Polonsky, Rebekah Young, et al.
Schizophrenia Research
|
January 12, 2023
Longitudinal study of inflammation and relapse in schizophrenia
Brian J Miller, Henrique Lemos, Nina R Schooler, et al.
Journal of the American Society of Hypertension : JASH
|
October 5, 2016
The association between Self-Reported Medication Adherence scores and systolic blood pressure control: a SPRINT baseline data study
William E Haley, Olivia N Gilbert, Robert F Riley, et al.
Journal of the American College of Cardiology
|
July 17, 2012
Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute
Mark A Hlatky, Pamela S Douglas, Nakela L Cook, et al.
Schizophrenia Research
|
July 24, 2017
Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?
Anilkumar Pillai, Nina R Schooler, Diya Peter, et al.
Stroke
|
May 26, 2012
Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association
Daniel T Lackland, Mitchell S V Elkind, Ralph D'Agostino, et al.
Journal of Clinical Psychopharmacology
|
April 5, 2021
Association of Aripiprazole With Reduced Hippocampal Atrophy During Maintenance Treatment of First-Episode Schizophrenia
John Wang, Kamber L Hart, Wei Qi, et al.
Page
of 53
Search research articles
Search
Showing results (481-490 of 527) with videos related to
Sort By:
Page
of 53
The New England Journal of Medicine
|
June 10, 2008
Effects of intensive glucose lowering in type 2 diabetes
, Hertzel C Gerstein, Michael E Miller, et al.
The New England Journal of Medicine
|
March 4, 2011
Long-term effects of intensive glucose lowering on cardiovascular outcomes
, Hertzel C Gerstein, Michael E Miller, et al.
Human Genetics
|
March 30, 2017
Genetic associations with lipoprotein subfraction measures differ by ethnicity in the multi-ethnic study of atherosclerosis (MESA)
Zhe Wang, Ani Manichukal, David C Goff, et al.
Circulation
|
July 31, 2015
Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines
Joseph Yeboah, Tamar S Polonsky, Rebekah Young, et al.
Schizophrenia Research
|
January 12, 2023
Longitudinal study of inflammation and relapse in schizophrenia
Brian J Miller, Henrique Lemos, Nina R Schooler, et al.
Journal of the American Society of Hypertension : JASH
|
October 5, 2016
The association between Self-Reported Medication Adherence scores and systolic blood pressure control: a SPRINT baseline data study
William E Haley, Olivia N Gilbert, Robert F Riley, et al.
Journal of the American College of Cardiology
|
July 17, 2012
Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute
Mark A Hlatky, Pamela S Douglas, Nakela L Cook, et al.
Schizophrenia Research
|
July 24, 2017
Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?
Anilkumar Pillai, Nina R Schooler, Diya Peter, et al.
Stroke
|
May 26, 2012
Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association
Daniel T Lackland, Mitchell S V Elkind, Ralph D'Agostino, et al.
Journal of Clinical Psychopharmacology
|
April 5, 2021
Association of Aripiprazole With Reduced Hippocampal Atrophy During Maintenance Treatment of First-Episode Schizophrenia
John Wang, Kamber L Hart, Wei Qi, et al.
Page
of 53